Catalyst Capital Advisors LLC Trans Medics Group, Inc. Transaction History
Catalyst Capital Advisors LLC
- $4.66 Billion
- Q4 2024
A detailed history of Catalyst Capital Advisors LLC transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Catalyst Capital Advisors LLC holds 4,800 shares of TMDX stock, worth $331,152. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,800
Previous 4,800
-0.0%
Holding current value
$331,152
Previous $753,000
60.29%
% of portfolio
0.01%
Previous 0.02%
Shares
5 transactions
Others Institutions Holding TMDX
# of Institutions
346Shares Held
30.6MCall Options Held
671KPut Options Held
858K-
Vanguard Group Inc Valley Forge, PA3.64MShares$251 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$183 Million0.01% of portfolio
-
State Street Corp Boston, MA1.36MShares$93.9 Million0.0% of portfolio
-
Fil LTD Hamilton, D01MShares$69 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3993KShares$68.5 Million0.07% of portfolio
About TransMedics Group, Inc.
- Ticker TMDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 31,831,400
- Market Cap $2.2B
- Description
- TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...